Package 63941-274-02

{"route": ["ORAL"], "spl_id": "45b2c593-0e11-3488-e063-6394a90ad6f0", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "upc": ["0070038629337"], "unii": ["362O9ITL9D", "9D2RTI9KYH", "495W7451VQ", "04JA59TNSJ"], "rxcui": ["1098435"], "spl_set_id": ["f6401b58-8cf8-4067-e053-2995a90a68fc"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["VALU MERCHANDISERS COMPANY"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 BLISTER PACK in 1 CARTON (63941-274-02)  / 12 TABLET, COATED in 1 BLISTER PACK", "package_ndc": "63941-274-02", "marketing_end_date": "20271031", "marketing_start_date": "20230414"}], "brand_name": "Head Congestion plus Flu Severe PE", "product_id": "63941-274_45b2c593-0e11-3488-e063-6394a90ad6f0", "dosage_form": "TABLET, COATED", "pharm_class": ["Adrenergic alpha1-Agonists [MoA]", "Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "Sigma-1 Agonist [EPC]", "Sigma-1 Receptor Agonists [MoA]", "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]", "Uncompetitive NMDA Receptor Antagonists [MoA]", "alpha-1 Adrenergic Agonist [EPC]"], "product_ndc": "63941-274", "generic_name": "ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE", "labeler_name": "VALU MERCHANDISERS COMPANY", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Head Congestion plus Flu Severe PE", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "325 mg/1"}, {"name": "DEXTROMETHORPHAN HYDROBROMIDE", "strength": "10 mg/1"}, {"name": "GUAIFENESIN", "strength": "100 mg/1"}, {"name": "PHENYLEPHRINE HYDROCHLORIDE", "strength": "5 mg/1"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_end_date": "20271031", "marketing_start_date": "20230414"}